NEW YORK, June 5 (Reuters) - Mylan Inc said on Thursday it settled patent litigation with Abbott Laboratories Inc over Abbott's Depakote ER drug for epilepsy and bipolar disorder that allows the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results